Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,769Revenue $M688Net Margin (%)-3.6Z-Score1.7
Enterprise Value $M1,656EPS $0.3Operating Margin %-6.4F-Score3
P/E(ttm))0Cash Flow Per Share $1.5Pre-tax Margin (%)-6.8Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %0Quick Ratio3.5Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %0Current Ratio4.0Lower Leverage y-yY
Price/Cash Flow14.3y-y EBITDA Growth Rate %-94.9ROA % (ttm)-1.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-2.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M65.4ROI % (ttm)3.7Gross Margin Increase y-yN

Gurus Latest Trades with MDCO

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDCOJoel Greenblatt 2014-09-30 Reduce-0.06%$22.95 - $29.64
($25.38)
$ 27.046%Reduce -87.68%24,009
MDCOGeorge Soros 2014-09-30 Sold Out -0.02%$22.95 - $29.64
($25.38)
$ 27.046%Sold Out0
MDCOJoel Greenblatt 2014-06-30 Buy 0.07%$24.02 - $29.57
($26.67)
$ 27.041%New holding, 194954 sh.194,954
MDCOGeorge Soros 2014-06-30 Buy 0.02%$24.02 - $29.57
($26.67)
$ 27.041%New holding, 75000 sh.75,000
MDCOJohn Hussman 2014-06-30 Sold Out -0.14%$24.02 - $29.57
($26.67)
$ 27.041%Sold Out0
MDCOJohn Hussman 2014-03-31 Reduce-0.1%$27.9 - $40.39
($33.42)
$ 27.04-19%Reduce -35.58%67,000
MDCOGeorge Soros 2014-03-31 Sold Out -0.02%$27.9 - $40.39
($33.35)
$ 27.04-19%Sold Out0
MDCOJoel Greenblatt 2014-03-31 Sold Out -0.01%$27.9 - $40.39
($33.35)
$ 27.04-19%Sold Out0
MDCOJoel Greenblatt 2013-12-31 Buy 0.01%$31.48 - $38.91
($35.74)
$ 27.04-24%New holding, 13990 sh.13,990
MDCOGeorge Soros 2013-12-31 Reduce-0.07%$31.48 - $38.91
($35.74)
$ 27.04-24%Reduce -80%50,000
MDCOVanguard Health Care Fund 2013-09-30 Add0.33%$29.68 - $34.54
($31.83)
$ 27.04-15%Add 219.22%4,250,415
MDCOGeorge Soros 2013-09-30 Add0.04%$29.68 - $34.54
($31.83)
$ 27.04-15%Add 66.67%250,000
MDCOJohn Hussman 2013-09-30 Reduce-0.57%$29.68 - $34.54
($31.83)
$ 27.04-15%Reduce -79.73%104,000
MDCOVanguard Health Care Fund 2013-06-30 Add0.1%$30.76 - $37.1
($33.46)
$ 27.04-19%Add 181.56%1,331,500
MDCOGeorge Soros 2013-06-30 Add0.02%$30.76 - $37.1
($33.46)
$ 27.04-19%Add 57.89%150,000
MDCOJohn Hussman 2013-06-30 Reduce-0.22%$30.76 - $37.1
($33.46)
$ 27.04-19%Reduce -26.29%513,000
MDCOVanguard Health Care Fund 2013-03-31 Buy 0.06%$23.97 - $33.41
($30.53)
$ 27.04-11%New holding, 472900 sh.472,900
MDCOGeorge Soros 2013-03-31 Buy 0.04%$23.97 - $33.41
($30.53)
$ 27.04-11%New holding, 95000 sh.95,000
MDCOJohn Burbank 2013-03-31 Sold Out -0.09%$23.97 - $33.41
($30.53)
$ 27.04-11%Sold Out0
MDCOJohn Burbank 2012-12-31 Buy 0.09%$20.34 - $26.64
($22.78)
$ 27.0419%New holding, 100000 sh.100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDCO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MDCO Vanguard Health Care Fund 2014-09-304,762,7307.280.27+1.33%
MDCO Joel Greenblatt 2014-09-3024,0090.040.01-87.68%
MDCO George Soros 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MDCO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
O'Connor William BernardSr VP & Chief Acct. Officer 2014-03-03Sell2,968$30.31-11.84view
MEANWELL CLIVEChairman & CEO 2014-02-03Sell10,000$34.29-22.08view
Antinori Paul MichaelSr. VP & General Counsel 2014-01-21Sell37,883$38.02-29.72view
O'Connor William BernardSr VP & Chief Acct. Officer 2014-01-15Sell4,427$39.15-31.75view
O'Connor William BernardSr VP & Chief Acct. Officer 2014-01-10Sell72,384$40-33.2view
MEANWELL CLIVEChairman & CEO 2014-01-07Sell27,929$38.13-29.92view
MEANWELL CLIVEChairman & CEO 2014-01-03Sell57,516$38.16-29.98view
Antinori Paul MichaelSr. VP & General Counsel 2013-12-13Sell19,600$36.96-27.71view
CROUSE WILLIAMDirector 2013-12-09Sell12,500$38-29.68view
SBLENDORIO GLENNPresident & CFO 2013-12-05Sell8,516$38.5-30.6view

Press Releases about MDCO :

    Quarterly/Annual Reports about MDCO:

    News about MDCO:

    Articles On GuruFocus.com
    Chuck Royce Buys Stifel Financial, Tidewater, Alamos, Sells Kennametal, Gardner Denver, Gartner Apr 25 2013 
    Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD Jan 27 2013 
    Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS Jan 21 2013 
    George Soros' Top Buys in the Last Quarter Dec 23 2011 
    George Soros Buys Amazon.com Inc., Motorola Solutions, Sandisk, Sells Ralph Lauren, Dendreon, Lawson Nov 15 2011 
    Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 100,000 Shares Mar 01 2011 
    Medicines Company Reports Operating Results (10-Q) Nov 09 2010 
    Medicines Company Reports Operating Results (10-Q) May 10 2010 
    Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 181,500 Shares May 04 2010 
    Medicines Company Reports Operating Results (10-Q) Nov 09 2009 

    More From Our Partners
    Alnylam Provides Pipeline Update, Growth Strategy - Analyst Blog Dec 15 2014 - ZACKS

    More From Other Websites
    Alnylam and The Medicines Company Announce Initiation of Phase 1 Clinical Trial for ALN-PCSsc, a... Dec 11 2014
    Alnylam and The Medicines Company Announce Initiation of Phase 1 Clinical Trial for ALN-PCSsc, a... Dec 11 2014
    Alnylam and The Medicines Company Announce Initiation of Phase 1 Clinical Trial for ALN-PCSsc, a... Dec 11 2014
    The Medicines Company to Participate in Oppenheimer 25th Annual Healthcare Conference Dec 08 2014
    The Medicines Company Surges Amid Credit Suisse Upgrade Nov 20 2014
    The Medicines Company Presents New Phase 1 Data Showing Investigational Agent MDCO-216 Modified Key... Nov 16 2014
    The Medicines Company Presents New Phase 1 Data Showing Investigational Agent MDCO-216 Modified Key... Nov 16 2014
    MEDICINES CO /DE Financials Nov 14 2014
    The Medicines Company to Present New Data on Investigational Lipid-Modifying Agent MDCO-216 and... Nov 14 2014
    The Medicines Company to Present New Data on Investigational Lipid-Modifying Agent MDCO-216 and... Nov 14 2014
    The Medicines Company to Participate in Credit Suisse Healthcare Conference Nov 11 2014
    The Medicines Company to Participate in Credit Suisse Healthcare Conference Nov 11 2014
    10-Q for The Medicines Co. Nov 09 2014
    MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report Nov 07 2014
    Health Economic Data on The Medicines Company’s Infectious Disease and Cardiology Portfolios to be... Nov 07 2014
    Health Economic Data on The Medicines Company’s Infectious Disease and Cardiology Portfolios to be... Nov 07 2014
    MEDICINES CO /DE Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 05 2014
    The Medicines Company Announces First Patient Enrollment in Phase 3 Studies of CARBAVANCE™ in... Nov 05 2014
    Update to The Medicines Company Investor & Analyst Day on November 5 Nov 04 2014
    The Medicines Company to Webcast Investor & Analyst Day on November 5 Oct 30 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK